ANXA1Ac2-26 peptide, a possible therapeutic approach in inflammatory ocular diseases (2017)
Source: Gene. Unidades: FCFRP, FMRP
Subjects: CITOCINAS, EXPRESSÃO GÊNICA, OFTALMOPATIAS, REAÇÃO EM CADEIA POR POLIMERASE
ABNT
CARDIN, Laila Toniol et al. ANXA1Ac2-26 peptide, a possible therapeutic approach in inflammatory ocular diseases. Gene, v. 614, p. 26-36, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.gene.2017.02.032. Acesso em: 02 out. 2024.APA
Cardin, L. T., Sonehara, N. M., Mimura, K. K. O., Santos, A. R. D. dos, Silva Júnior, W. A. da, Sobral, L. M., et al. (2017). ANXA1Ac2-26 peptide, a possible therapeutic approach in inflammatory ocular diseases. Gene, 614, 26-36. doi:10.1016/j.gene.2017.02.032NLM
Cardin LT, Sonehara NM, Mimura KKO, Santos ARD dos, Silva Júnior WA da, Sobral LM, Leopoldino AM, Cunha BR da, Tajara EH, Oliani SM, Rodrigues-Lisoni FC. ANXA1Ac2-26 peptide, a possible therapeutic approach in inflammatory ocular diseases [Internet]. Gene. 2017 ; 614 26-36.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/j.gene.2017.02.032Vancouver
Cardin LT, Sonehara NM, Mimura KKO, Santos ARD dos, Silva Júnior WA da, Sobral LM, Leopoldino AM, Cunha BR da, Tajara EH, Oliani SM, Rodrigues-Lisoni FC. ANXA1Ac2-26 peptide, a possible therapeutic approach in inflammatory ocular diseases [Internet]. Gene. 2017 ; 614 26-36.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/j.gene.2017.02.032